96906 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Alzheimer's disease; Amyloid plaque core protein
Amyloid β gene vaccines
#602Amyloid Formation
#603Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
#604Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#605Arctic β amyloid protofibril
#606Amyloid beta protein channel structure and uses thereof in identifying potential drug molecules for neurodegenerative diseases
#607Compositions and methods for treating atherosclerosis
#608COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND DISEASES
#609Modulation of Abeta levels by beta-secretase BACE2
#610Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
#611Amyloid beta peptide analogs and assemblies thereof
#612Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
#613Inhibition of tau-tau-association
#614Beta-secretase substrates and uses thereof
#615Transgenic mouse expressing an APP 670/671 mutation
#616PROCESS FOR IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN MOUSE MODELS OF ALZHEIMER'S DISEASE INCLUDING TRIPLE TRANSGENIC MICE AND PRODUCTS THEREBY
#617HUMAN DISEASE MODELING USING SOMATIC GENE TRANSFER
#618Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
#619Peptides and methods using same for diagnosing and treating amyloid-associated diseases
#620Insulin epitopes for the treatment of type 1 diabetes
#621TRANSGENIC MICE COMPRISING A GENOMIC HUMAN TAU TRANSGENE
#622Marker peptide for alzheimer's disease
#623Invertebrate animal model with neurodegenerative phenotype for screening and testing substances
#624Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site
#625Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#626Amyloid specific binding peptides and detecting abeta peptide
#627Secreted proteins
#628Detoxification depot for Alzheimer's disease
#629Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
#630Soluble low-density lipoprotein receptor related protein binds directly to Alzheimer's amyloid-beta peptide
#631Anti-ADDL antibodies and uses thereof
#632NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#633Methods for modulating transcriptional activation using mint proteins
#634Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
#635Inhibitors of amyloid precursor protein processing
#636Tau hyperphosphorylation in transgenic mice expressing the APP double mutation
#637Novel treatment
#638Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#639Compounds for inhibiting diseases and preparing cells for transplantation
#640Stabilized immunogenic HBc chimer particles
#641Apolipoprotein biopolymer marker indicative of normal human
#642Method for the production of amyloid-beta peptide using ubiquitin
#643Transgenic Alzheimer's mouse model vectors and uses thereof
#644Assays to monitor amyloid precursor protein processing
#645ASP2
#646ASP2
#647Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases
#648Agglomeration protein cascades, compositions and methods regarding the same
#649Abeta antibodies for use in improving cognition
#650Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
#651Reagent for amplifying amyloid fibrosis of amyloid ss-protein
#652Peptides directed for diagnosis and treatment of amyloid-associated disease
#653Treatment of neurodegenerative diseases
#654Human cDNAs and proteins and uses thereof
#655Gamma-secretase inhibitors
#656Alzheimer's related proteins and methods of use
#657Novel beta-secretase and modulation of beta-secretase activity
#658Amyloid beta protein (globular assembly and uses thereof)
#659Transgenic animals as models for neurodegenerative disease
#660Truncated tau proteins
#661Amyloid β protein (globular assembly and uses thereof)
#662Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
#663Method of screening compound affecting amyloid beta production
#664Signaling intermediates in an in vitro model of Alzheimer's disease
#665HSP20 inhibits amyloidogenesis and neurotoxicity
#666Method for crystallizing human beta secretase in complex with an inhibitor
#667Methods for the treatment of alzheimers disease and compositions therefore
#668Method of reducing the effects of Abeta and compositions therefore
#669Transgenic animal expressing alzheimer's tau protein
#670Methods for preventing and treating Alzheimer's disease
#671Compositions and methods for treating atherosclerosis
#672Methods for the identification of compounds for the treatment of Alzheimer's disease
#673Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
#674Insulin degrading enzyme assays for treatment of alzheimer's disease
#675Biopolymer markers indicative of type II diabetes
#676Methods and compositions comprising supramolecular constructs
#677Methods and compositions for diseases associated with amyloidosis
#678Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide
#679Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
#680An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
#681Optimization of transgene expression in mammalian cells
#682Prevention and treatment of amyloidogenic disease
#683Prevention and treatment of amyloidogenic disease
#684Genomic mammary Amyloid a sequence
#685Human brain carboxypeptidase B antibodies
#686Complex of a chaperone with β-amyloid and methods employing this complex
#687Modulators of β-amyloid peptide aggregation comprising D-amino acids
#688Inhibition of tau-tau-association
#689Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
#690Components of the presenilin-complex
#691β-amyloid peptide-binding proteins and polynucleotides encoding the same
#692Novel treatment
#693Helical peptidomimetics with enhanced activity
#694Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)
#695Methods and compositions relating to prion-only transmission of yeast strains
#696Purified antigen for Alzheimer's disease and methods of obtaining and using same
#697Prevention and treatment of amyloidogenic disease
#698Humanized antibodies that recognize beta amyloid peptide
#699Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
#700Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease
#701Methods of diagnosing or treating neurological diseases and cell degeneration
#702Neuroprotective polypeptides and methods of use
#703Recombinant prion-like genes and proteins and materials and methods comprising the same
#704Antibody specific for mutant presenilin 1
#705G protein-binding proteins and polynucleotides encoding the same
#706Amyloid-β protein aggregation-regulating factors
#707Compounds for the diagnosis/prevention/treatment of alzheimer's disease
#708Prevention and treatment of amyloidogenic disease
#709Alzheimer's disease secretase, APP substrates thereof, and uses thereof
#710Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
#711Prevention and treatment of amyloidogenic disease
#712Prevention and treatment of amyloidogenic disease
#713Prion inhibiting peptides and derivatives thereof
#714Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#715G protein-binding proteins and polynucleotides encoding the same
#716Anti-amyloid β antibodies
#717Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
#718Prevention and treatment of amyloidogenic disease
#719Novel method for down-regulation of amyloid
#720Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
#721Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#722Test and model for Alzheimer's disease
#723Inhibitors of amyloid precursor protein processing
#724Prevention and treatment of amyloidogenic disease
#725Identification of genes involved in Alzheimer's disease using Drosophila melanogaster
#726Modulators of β-amyloid peptide aggregation
#727Amyloid beta is a ligand for FPR class receptors
#728Type1 diabetes diagnostics and therapeutics
#729Regulated nucleic acids in pathogenesis of alzheimer's disease
#730Amyloid beta-peptide and methods of use
#731Anti-fibril peptides
#732Model for neurodegenerative disorders
#733Compositions and methods for treating inflammatory disorders
#734Mammary-associated serum amuloid a3 promoter sequences and used for same
#735Ligand binding of amyloid peptide protein epitope
#736Saitohin gene and uses of same
#737ASP2
#738β-amyloid peptide-binding proteins and polynucleotides encoding the same
#739Substrates and assays for beta-secretase
#740Amino acid composition with increased blood brain barrier permeability
#741Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition
#742Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
#743Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#744Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)
#745Alzheimer's disease secretase, app substrates therefor, and uses therefor
#746Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
#747Medicinal compositions
#748Gamma three protease
#749Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
#750Prevention and treatment of amyloidogenic disease
#751Prevention and treatment of amyloidogenic disease
#752Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same
#753Prevention and treatment of amyloidogenic disease
#754Compositions and methods for diagnosing Alzheimer's disease
#755Prevention and treatment of amyloidogenic disease
#756Mouse showing neurofibril change due to senile dementia
#757Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
#758Beta-secretase substrates and uses thereof
#759Prevention and treatment of amyloidogenic disease
#760Alzheimer's disease secretase
#761β-Secretase variant
#762Detection of conformationally altered proteins and prions
#763Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation
#764Triple transgenic mouse model of Alzheimer's disease
#765Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#766Prevention and treatment of amyloidogenic disease
#767Prevention and treatment of amyloidogenic disease
#768Prevention and treatment of amyloidogenic disease
#769Method of inducing the formation of neurofibrillary tangles in transgenic animals
#770Prevention and treatment of amyloidogenic disease
#771Protein inhibiting aggregation of beta amyloid peptide
#772Humanized antibodies that recognize beta amyloid peptide
#773Tau-opathy model